Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
InterMedical Care and Lab Hospital PCL's EBIT per Share for the
three
months ended in Mar. 2026 was ฿0.21.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ฿-0.44.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
During the past 10 years, the highest 3-Year average EBIT per Share Growth Rate of InterMedical Care and Lab Hospital PCL was 192.40% per year. The lowest was 127.60% per year. And the median was 160.00% per year.
BKK:IMH's 3-Year EBIT Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 12.05 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
InterMedical Care and Lab Hospital PCL (BKK:IMH) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
InterMedical Care and Lab Hospital PCL EBIT per Share Related Terms
InterMedical Care and Lab Hospital PCL EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InterMedical Care and Lab Hospital PCL EBIT per Share Chart
InterMedical Care and Lab Hospital PCL Annual Data
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿-0.44
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InterMedical Care and Lab Hospital PCL (BKK:IMH) has a EBIT per Share of ฿-0.44 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on InterMedical Care and Lab Hospital PCL and its competitors. According to the industry distribution chart, InterMedical Care and Lab Hospital PCL ranks #999999 out of 526 companies in the Healthcare Providers & Services industry.
Is InterMedical Care and Lab Hospital PCL's EBIT per Share too high?
InterMedical Care and Lab Hospital PCL's current EBIT per Share is ฿-0.44. Based on the distribution chart, InterMedical Care and Lab Hospital PCL ranks #999999 out of 526 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, InterMedical Care and Lab Hospital PCL has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does InterMedical Care and Lab Hospital PCL's EBIT per Share compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, InterMedical Care and Lab Hospital PCL ranks #999999 out of 526 companies for EBIT per Share. This places InterMedical Care and Lab Hospital PCL in the lower half of its industry. The industry median EBIT per Share is 12.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 12.05, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on InterMedical Care and Lab Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 12.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InterMedical Care and Lab Hospital PCL's current EBIT per Share is ฿-0.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InterMedical Care and Lab Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, InterMedical Care and Lab Hospital PCL (BKK:IMH) is currently considered Possible Value Trap. The stock's GF Value™ is ฿4.43, compared to a current price of ฿2.98 — trading 32.7% below its estimated fair value. The current EBIT per Share is ฿-0.44. InterMedical Care and Lab Hospital PCL's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For InterMedical Care and Lab Hospital PCL (BKK:IMH), the current EBIT per Share is ฿-0.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InterMedical Care and Lab Hospital PCL (BKK:IMH) Overvalued in 2026?
Based on GuruFocus' analysis, InterMedical Care and Lab Hospital PCL stock appears to be undervalued.
The current stock price of ฿2.98 is trading 32.7% below its estimated GF Value™ of ฿4.43.
GuruFocus considers InterMedical Care and Lab Hospital PCL to be Possible Value Trap.
Key valuation signals for BKK:IMH:
EBIT per Share: ฿-0.44
GF Value™: ฿4.43 vs. price of ฿2.98 (32.7% below fair value)
No single metric tells the full story. See the BKK:IMH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InterMedical Care and Lab Hospital PCL Business Description
InterMedical Care and Lab Hospital PCL is a company principally engaged in specialty medical hospitals, and occupational medicine. The business segments of the firm are Prachapat hospital, Occupational Medicine hospital and Environmental Analysis. Prachapat Hospital is engaged in rendering medical services to patients under government welfare schemes. Occupational Medicine Hospital is engaged in providing physical examination services. Majority of revenue is from Hospital Segment. Geographically, the company operates in Thailand.
58GF Score
Get the complete analysis for BKK:IMH
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:IMH has been successfully added to your 
